Under construction – not a live service
Sign in
Taking peopleNo phase

Tests extra intensive arm training soon after stroke

Tests extra daily arm training for stroke survivors in the early recovery period.

Plain-language title generated from the registry record
Registry title: The Efficacy of Additional Motor Training Dosage During the Early Stages Post Stroke on the Upper Extremity Recovery

Key facts

Where
Ofakim, IsraelSee the site

Where in Israel

  • Adi-Negev Nahalat EranOfakim, IsraelNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Adi Negev-Nahalat Eran
Trial code
NCT07056049
Record updated
17 July 2025
Original description
Intervention abstractRead full original descriptionShow less

Efficacy of High-dosage, High-intensity Rehabilitation Program on the Motor Recovery After Stroke in Subacute Patients

Intervention abstract

Background: Stroke is the leading cause of long-term disability, and the second leading cause of death in the western world. Most stroke survivors will suffer from motor and cognitive disturbances for the rest of their life, which negatively affects their normal daily life.

Despite the decline in stroke-related mortality over the past decades, the outcome of rehabilitation programs does not improve, and is predictable regardless of the program used. Still, several human and animal studies show that high capacity of training in the early stages post stroke improve motor recovery. This notion is far from being well established.

Aim: Studying the effect of high-dosage, high-intensity training program in the subacute period on upper extremity motor recovery.

Population: Stroke survivors. Study duration: 6 months. Study protocol: Participants will receive additional technology-based upper extremity training for 120 min/day, 5d/w, 4 weeks. They will be monitored pre and post training, and 6 months post-stroke. Outcome measures will include clinical, kinematic and adherence measures (see complete list in the protocol).

Inclusion: Age ≥18 years; Ischemic or hemorrhagic stroke (hemispheric or brainstem) confirmed by CT or MRI; First-ever stroke or previous stroke with no upper extremity weakness; 1 week ≤ Time after stroke onset ≤ 6 weeks; Active shoulder flexion of at least 20◦ and partial wrist and/or finger active movement; Ability to provide inform consent.

Exclusion: Cognitive or communication impairments as determined by the clinical team Unstable medical conditions; A painful shoulder limiting an active forward reach; Severe spasticity or non-neural loss of range of motion.

ClinicalTrials.gov NCT07056049